Stock listing
Dusseldorf:EII Eisai Co., Ltd. Aktie
German listing (Dusseldorf) of Eisai Co., Ltd. · home listing Tokyo:4523
Follow Eisai Co., Ltd. into a list and get an email when it puts out news.
Share price · DUS:EII
€29.49 EUR -0.27 (-0.9%)
Close on Nov 20, 2026
- Day range
- €29.49 – €30.00 EURNov 20, 2026
- Market cap
- €16.49B EURAt the close on Nov 20, 2026 · price × 559.1M shares outstanding
- 52-week range
- €19.41 – €30.91 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €319 EURMedian day 0 shares · 55 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| OTC:ESAIY | $8.28 USD | +0.06 (+0.7%) | 500 | $8.25 | $8.28 | $8.25 | $8.22 | Close on Nov 20, 2026 |
| OTC:ESALF | $33.06 USD | +0.48 (+1.5%) | 200 | $33.06 | $33.06 | $33.06 | $32.58 | Close on Nov 16, 2026 |
| Frankfurt:EII | €29.71 EUR | -1.04 (-3.4%) | — | €29.61 | €29.71 | €29.61 | €30.75 | Close on Nov 20, 2026 |
| Munich:EII | €30.06 EUR | +0.01 (0.0%) | — | €30.06 | €30.06 | €30.06 | €30.05 | Close on Nov 20, 2026 |
| Dusseldorf:EII | €29.49 EUR | -0.27 (-0.9%) | — | €30.00 | €30.00 | €29.49 | €29.76 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · DUS:EII · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €27.54 | -2.749 | -9.1% | €26.95 | €27.65 | €26.93 | 0 | |
| €30.29 | +2.25 | +8.0% | €29.30 | €30.91 | €28.34 | 150 | |
| €28.04 | +0.385 | +1.4% | €28.03 | €28.11 | €27.69 | 0 | |
| €27.66 | -0.311 | -1.1% | €27.93 | €28.17 | €27.64 | 0 | |
| €27.97 | -0.275 | -1.0% | €28.10 | €28.60 | €27.97 | 0 | |
| €28.24 | +0.079 | +0.3% | €28.30 | €28.30 | €28.17 | 0 | |
| €28.17 | -0.803 | -2.8% | €28.19 | €28.37 | €27.86 | 0 | |
| €28.97 | -0.33 | -1.1% | €29.05 | €29.08 | €28.92 | 0 | |
| €29.30 | +0.123 | +0.4% | €29.03 | €29.33 | €28.89 | 0 | |
| €29.18 | +0.192 | +0.7% | €29.16 | €29.18 | €29.15 | 0 | |
| €28.98 | +1.049 | +3.8% | €28.66 | €28.99 | €28.52 | 0 | |
| €27.93 | -0.301 | -1.1% | €28.16 | €28.21 | €27.72 | 0 | |
| €28.24 | +0.35 | +1.3% | €28.10 | €28.26 | €27.93 | 0 | |
| €27.89 | +0.662 | +2.4% | €27.80 | €27.97 | €27.58 | 0 | |
| €27.22 | +0.19 | +0.7% | €27.28 | €27.28 | €27.14 | 500 | |
| €27.03 | -0.241 | -0.9% | €27.38 | €27.62 | €27.00 | 0 | |
| €27.27 | +1.086 | +4.1% | €27.17 | €27.66 | €27.10 | 0 | |
| €26.19 | +0.039 | +0.1% | €26.26 | €26.63 | €25.91 | 0 | |
| €26.15 | +0.382 | +1.5% | €26.15 | €26.15 | €26.15 | 0 | |
| €25.77 | +0.429 | +1.7% | €25.87 | €25.87 | €25.47 | 0 | |
| €25.34 | -0.263 | -1.0% | €25.58 | €25.58 | €25.28 | 0 | |
| €25.60 | -0.385 | -1.5% | €25.71 | €25.75 | €25.57 | 0 | |
| €25.99 | +0.127 | +0.5% | €26.08 | €26.15 | €25.84 | 0 | |
| €25.86 | -0.216 | -0.8% | €25.99 | €26.05 | €25.68 | 0 | |
| €26.08 | -0.289 | -1.1% | €26.20 | €26.44 | €25.76 | 0 | |
| €26.36 | -0.089 | -0.3% | €26.52 | €26.75 | €26.13 | 0 | |
| €26.45 | -0.568 | -2.1% | €26.63 | €26.92 | €26.32 | 0 | |
| €27.02 | +0.645 | +2.4% | €27.08 | €27.25 | €26.65 | 0 | |
| €26.38 | -0.935 | -3.4% | €26.62 | €26.68 | €26.38 | 0 | |
| €27.31 | -0.053 | -0.2% | €27.25 | €27.46 | €27.19 | 0 | |
| €27.36 | +0.425 | +1.6% | €27.46 | €27.54 | €27.36 | 0 | |
| €26.94 | -0.383 | -1.4% | €26.94 | €26.94 | €26.94 | 0 | |
| €27.32 | +0.046 | +0.2% | €27.32 | €27.56 | €27.18 | 0 | |
| €27.28 | -0.259 | -0.9% | €27.32 | €27.34 | €27.28 | 0 | |
| €27.54 | +0.318 | +1.2% | €26.81 | €27.57 | €26.57 | 0 | |
| €27.22 | -0.475 | -1.7% | €27.31 | €27.31 | €26.46 | 0 | |
| €27.69 | +0.925 | +3.5% | €27.56 | €27.81 | €27.30 | 0 | |
| €26.77 | +0.05 | +0.2% | €26.37 | €26.92 | €26.35 | 0 | |
| €26.72 | +0.602 | +2.3% | €26.58 | €26.72 | €26.17 | 0 | |
| €26.12 | +0.279 | +1.1% | €26.11 | €26.12 | €26.07 | 0 | |
| €25.84 | +0.264 | +1.0% | €25.78 | €25.85 | €25.47 | 0 | |
| €25.57 | -0.106 | -0.4% | €25.77 | €25.77 | €25.24 | 0 | |
| €25.68 | -0.181 | -0.7% | €25.77 | €25.80 | €25.66 | 0 | |
| €25.86 | +0.534 | +2.1% | €25.97 | €25.98 | €25.71 | 0 | |
| €25.33 | -0.566 | -2.2% | €25.33 | €25.33 | €25.33 | 0 | |
| €25.89 | -0.547 | -2.1% | €25.95 | €26.04 | €25.79 | 0 | |
| €26.44 | +1.252 | +5.0% | €26.07 | €26.51 | €26.03 | 0 | |
| €25.19 | +0.418 | +1.7% | €25.31 | €25.44 | €25.15 | 0 | |
| €24.77 | -0.251 | -1.0% | €25.23 | €25.32 | €24.75 | 0 | |
| €25.02 | -1.015 | -3.9% | €25.27 | €25.34 | €24.80 | 0 | |
| €26.03 | +0.274 | +1.1% | €25.84 | €26.14 | €25.68 | 0 | |
| €25.76 | -0.027 | -0.1% | €25.78 | €25.84 | €25.76 | 0 | |
| €25.79 | -0.312 | -1.2% | €25.79 | €25.84 | €25.70 | 0 | |
| €26.10 | +0.53 | +2.1% | €25.75 | €26.18 | €25.68 | 0 | |
| €25.57 | -0.642 | -2.4% | €25.64 | €25.81 | €25.41 | 0 | |
| €26.21 | -0.18 | -0.7% | €26.23 | €26.40 | €25.80 | 0 | |
| €26.39 | +0.257 | +1.0% | €26.48 | €26.85 | €26.06 | 0 |
- Ticker
- Dusseldorf:EII
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- Dusseldorf
- Currency
- EUR
What changed lately
Latest news release · Nov 12, 2026
LEQEMBI Pen (Subcutaneous Formulation of LEQEMBI) Now Available in Japan for Patients with Early Alzheimer’s Disease
Latest earnings call · Aug 3, 2026
Eisai (Tokyo:4523) Q1 2027 Earnings Call
Replay and transcript
Latest deck · Nov 10, 2026
Q2 2027 Earnings Presentation
Earnings · 33 slides
Latest news
Revenue of LEQEMBI (Preliminary Basis)
Oct 28, 2026
Closed €28.97 (-1.1%) on Oct 28, 2026
Notification Regarding Receipt of Dividend from a Consolidated Subsidiary
Oct 2, 2026
Closed €26.36 (-0.3%) on Oct 2, 2026
U.S. FDA Approves WELIREG® (belzutifan) Plus LENVIMA® (lenvatinib) for Certain Previously Treated Adult Patients With Advanced Renal Cell Carcinoma With a Clear Cell Component (ccRCC)
Sep 25, 2026
Closed €27.36 (+1.6%) on Sep 25, 2026
Leqembi® Pen subcutaneous formulation approved in Japan
Sep 16, 2026
Closed €26.77 (+0.2%) on Sep 16, 2026
LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Approved in Japan for the Treatment of Early Alzheimer’s Disease
Sep 16, 2026
Closed €26.77 (+0.2%) on Sep 16, 2026
Eisai and Osaka Prefecture Enter into Collaboration to Promote Awareness of Dementia and Mild Cognitive Impairment (MCI)
Sep 15, 2026
Closed €26.72 (+2.3%) on Sep 15, 2026
LEQEMBI (lecanemab) Subcutaneous Formulation as an Initiation Treatment for Early Alzheimer’s Disease Approved in China
Sep 3, 2026
Closed €26.44 (+5.0%) on Sep 3, 2026
Eisai Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 59 in the last 12 months · 89 in all · newest Nov 12, 2026 · oldest 2025
- Calls
- 8 calls with a replay · 8 with a transcript · latest Aug 3, 2026
- Decks
- 9 decks · latest Nov 10, 2026
Where Eisai Co., Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Tokyo:4523 エーザイ · Home listing | Tokyo | Japan | JPY |
| OTC:ESAIY | OTC | United States | USD |
| gettex:EII | gettex | Germany | EUR |
| OTC:ESALF | OTC | United States | USD |
| Tradegate:EII | Tradegate | Germany | EUR |
| LS Exchange:855526 | LS Exchange | Germany | EUR |
| Frankfurt:EII | Frankfurt | Germany | EUR |
| Lang & Schwarz:855526 | Lang & Schwarz | Germany | EUR |
| Hamburg:EII | Hamburg | Germany | EUR |
| Hanover:EII | Hanover | Germany | EUR |
| Munich:EII | Munich | Germany | EUR |
| Dusseldorf:EII · This page | Dusseldorf | Germany | EUR |
| BIVA:4523N | BIVA | Mexico | MXN |
| BMV:4523N | BMV | Mexico | MXN |
| Dusseldorf:EIIA | Dusseldorf | Germany | EUR |
| Frankfurt:EIIA | Frankfurt | Germany | EUR |
| Stuttgart:EII | Stuttgart | Germany | EUR |
Team and board
| Officer | Role |
|---|---|
| Eisai Co | Ltd. Investor Relations Department |
| Jenny Ljunggren | External Communications and Investor Relations ManagerE-mail: [email protected] |
| Oskar Bosson | VP Communications and Investor RelationsE-mail: [email protected] |
Events
| Call | When | Status |
|---|---|---|
| Eisai (Tokyo:4523) Q1 2027 Earnings Call | Mon, Aug 03, 2026 · 3:00 AM ET | Replay |
| Eisai (Tokyo:4523) Q4 2026 Earnings Call | Fri, May 15, 2026 · 3:00 AM ET | Replay |
| Eisai (Tokyo:4523) Q2 2026 Earnings Call | Fri, Nov 07, 2025 · 2:30 AM ET | Replay |
| Eisai (Tokyo:4523) Q1 2026 Earnings Call | Tue, Aug 05, 2025 · 2:30 AM ET | Replay |
| Eisai (Tokyo:4523) Q4 2025 Earnings Call | Thu, May 15, 2025 · 2:30 AM ET | Replay |
| Eisai (Tokyo:4523) Q2 2025 Earnings Call | Fri, Nov 08, 2024 · 1:00 AM ET | Replay |
| Eisai (Tokyo:4523) Q1 2025 Earnings Call | Fri, Aug 02, 2024 · 2:00 AM ET | Replay |
| Eisai (Tokyo:4523) Q4 2024 Earnings Call | Thu, May 16, 2024 · 2:00 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2027 Earnings Presentation | Earnings | 33 slides | Nov 10, 2026 |
| Q2 FY2026 Earnings Presentation | Earnings | 33 slides | Nov 10, 2026 |
| Q1 2027 Earnings Presentation | Earnings | 30 slides | Aug 3, 2026 |
| FY2025 Earnings Presentation | Earnings | 37 slides | May 15, 2026 |
| Corporate Update (November 2025) | Corporate update | 22 slides | Nov 13, 2025 |
| Q2 2026 Earnings Presentation | Earnings | 37 slides | Nov 7, 2025 |
| Fact Sheet (May 2014) | Fact sheet | 1 slide | May 2014 |
| Fact Sheet (March 2013) | Fact sheet | 1 slide | March 2013 |
| Fact Sheet (June 2011) | Fact sheet | 2 slides | June 2011 |
Filings
Cap table
Built by 6ix from Eisai Co., Ltd.’s releases
- Common shares
- 291,649,149
- Fully diluted
- 291,649,149
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 291,649,149 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 291,649,149 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Eisai Co Other companies: Nuvation Bio Inc. (Ltd. Investor Relations Department · Since at least Mar 26, 2026); Biogen Inc. (Investor Relations Department · Since at least Jan 25, 2026) | Ltd. Investor Relations Department · Since at least Mar 26, 2026 |
| Jenny Ljunggren | External Communications and Investor Relations ManagerE-mail: [email protected] · Since at least Sep 16, 2026 |
| Oskar Bosson | VP Communications and Investor RelationsE-mail: [email protected] · Since at least Sep 16, 2026 |
Log in to ask 6ix AI your own questions about Eisai Co., Ltd.